The deal, which was being negotiated under the Trump administration's "America First Global Health Strategy," was intended to support Ghana's health programmes — including efforts against HIV/AIDS, malaria, and tuberculosis — over a five-year period. Negotiations between both sides began in November 2025 and, by all accounts, started on relatively smooth ground. However, things grew increasingly tense as the talks progressed, with pressure from the American side intensifying as the deadline approached.
Washington set April 24, 2026 as the cutoff for concluding the deal. Ghana's response was clear — Accra could not accept the terms as proposed and formally communicated its rejection to the Trump administration.
At the heart of Ghana's refusal was the question of who controls the country's health data. The proposed agreement would have given the US sweeping access to Ghana's health data and digital health infrastructure — a condition that government officials, public health experts, and civil society groups found unacceptable. The position taken by Accra is that a citizen's health information is among the most sensitive data a state holds, and it must remain firmly under national control — not traded away in exchange for foreign financing.
Ghana is not alone in pushing back. Zimbabwe walked away from a similar deal earlier in 2026, Zambia also declined, and in Kenya, a court stepped in to suspend implementation of a related agreement following legal challenges over data privacy.
The rejection does not affect existing health cooperation between Ghana and the US, but it marks a significant moment — one that signals Africa's growing resolve to assert data sovereignty even when substantial funding is on the table. In 2024, the US disbursed $219 million in total assistance to Ghana, including $96 million earmarked specifically for health, underscoring just how much is at stake in this standoff.
